<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="chapter-article"><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><?noissn?><front><journal-meta><journal-id journal-id-type="publisher-id">978-94-007-6214-5</journal-id><journal-id journal-id-type="doi">10.1007/978-94-007-6214-5</journal-id><journal-id journal-id-type="nlm-ta">Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds</journal-id><journal-title-group><journal-title>Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds</journal-title></journal-title-group><isbn publication-format="print">978-94-007-6213-8</isbn><isbn publication-format="electronic">978-94-007-6214-5</isbn></journal-meta><article-meta><article-id pub-id-type="pmcid">7120034</article-id><article-id pub-id-type="publisher-id">5</article-id><article-id pub-id-type="doi">10.1007/978-94-007-6214-5_5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Medicinal Applications of Plant Lectins</article-title></title-group><contrib-group content-type="book editors"><contrib contrib-type="editor"><name><surname>Fang</surname><given-names>Evandro Fei</given-names></name><address><phone>4105588162</phone><fax>4105588157</fax><email>fangfei1030@yahoo.com.cn</email></address><xref ref-type="aff" rid="AffID1">1</xref></contrib><contrib contrib-type="editor"><name><surname>Ng</surname><given-names>Tzi Bun</given-names></name><address><phone>39438031</phone><fax>26035123</fax><email>b021770@mailserv.cuhk.edu.hk</email></address><xref ref-type="aff" rid="AffID2">2</xref></contrib><aff id="AffID1"><label>ID1</label><institution-wrap><institution-id institution-id-type="GRID">grid.419475.a</institution-id><institution-id institution-id-type="ISNI">0000000093724913</institution-id><institution>, Laboratory of Molecular Gerontology, </institution><institution>National Institute on Aging, NIH, </institution></institution-wrap>Bayview Boulevard Street 251, Baltimore, 21224-6825 Maryland USA </aff><aff id="AffID2"><label>ID2</label><institution-wrap><institution-id institution-id-type="GRID">grid.10784.3a</institution-id><institution-id institution-id-type="ISNI">0000000419370482</institution-id><institution>, School of Biomedical Sciences, </institution><institution>The Chinese University of Hong Kong, </institution></institution-wrap>Shatin, Hong Kong, Hong Kong SAR </aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Bah</surname><given-names>Clara Shui Fern</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><bio><sec id="d29e189"><title>Clara Bah</title><p>completed her Bachelor&#x02019;s Degree in Chemical-Bioprocess Engineering at the University of Technology, Malaysia (UTM). After working as a research and development engineer, she completed a Postgraduate Diploma and Master&#x02019;s of Science (Food Science) at the University of Otago, New Zealand. Her research topic explored the availability of bioactive compounds from fish eggs, with a particular focus on lectins. This work led to collaboration with Dr Evandro Fang and Prof. T.B. Ng of the School of Biomedical Sciences in the Chinese University of Hong Kong. Currently Clara is working towards completing her PhD at the University of Otago</p></sec></bio></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Fang</surname><given-names>Evandro Fei</given-names></name><address><email>fange@mail.nih.gov</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><bio><sec id="d29e206"><title>Dr. Evandro Fei Fang</title><p>Dr. Evandro Fei Fang received his Ph.D. degree from The Chinese University of Hong Kong and currently works with Prof. Vilhelm A. Bohr on DNA repair and genome stability in human aging diseases. His research encompasses: (a) bioassay-guided isolation of antitumor constituents from medicinal plants and the molecular mechanisms involving apoptosis and autophagy pathways, and (b) the functions of mitochondria and mitophagy in sustaining human health and the molecular basis of their defects in the etiology of aging diseases. He has published over 30 papers in International Journals and 9 Book Chapters, and serves on the editorial board of Medicinal and Aromatic Plants. He was a finalist in the Young Investigator Award 2011 conducted by the Hong Kong Institute of Science.</p></sec></bio></contrib><contrib contrib-type="author"><name><surname>Ng</surname><given-names>Tzi Bun</given-names></name><address><email>b021770@mailserv.cuhk.edu.hk</email></address><xref ref-type="aff" rid="Aff3">3</xref><bio><sec id="d29e223"><title>Tzi Bun Ng</title><p>Tzi Bun Ng is Professor of Biochemistry at the Faculty of Medicine, The Chinese University of Hong Kong, HKSAR. After completing his B.Sc. studies at The University of Hong Kong, he obtained his Ph.D. degree from the Memorial University of Newfoundland in Canada. He pursued his postdoctoral training at University of California, San Francisco, USA, and sabbatical research at the Imperial College London, UK. His major research interests are the health-benefits of proteins and peptides including polysaccharopeptides, lectins, antimicrobial peptides, enzymes and protease inhibitors. In the past 30 years, his team made many contributions to the field of bioactive components, represented in more than 550 papers in International Peer-Reviewed Journals, over 60 invited Book Chapters, 2 Edited Books, and numerous other media. He currently sits on the editorial board of 9 International Journals and contributes actively in many scientific fields.</p></sec></bio></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.29980.3a</institution-id><institution-id institution-id-type="ISNI">0000000419367830</institution-id><institution>Department of Food Science, Division of Sciences, </institution><institution>University of Otago, </institution></institution-wrap>North Dunedin, New Zealand </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.94365.3d</institution-id><institution-id institution-id-type="ISNI">0000000122975165</institution-id><institution>Laboratory of Molecular Gerontology, National Institute on Aging, </institution><institution>National Institutes of Health, </institution></institution-wrap>Baltimore, MD 21224 USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.10784.3a</institution-id><institution-id institution-id-type="ISNI">0000000419370482</institution-id><institution>School of Biomedical Sciences, Faculty of Medicine, </institution><institution>The Chinese University of Hong Kong, </institution></institution-wrap>Hong Kong, Hong Kong </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>12</month><year>2012</year></pub-date><fpage>55</fpage><lpage>74</lpage><permissions><copyright-statement>&#x000a9; Springer Science+Business Media Dordrecht 2013</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p>Plant lectins are a unique group of proteins and glycoproteins with potent biological activity and have received widespread attention for many years. They can be found in wheat, corn, tomatoes, peanuts, kidney beans, bananas, peas, lentils, soybeans, mushrooms, tubers, seeds, mistletoe and potatoes among many others. Due to their ability to bind reversibly with specific carbohydrate structures and their abundant availability, plant lectins have commonly been used as a molecular tool in various disciplines of biology and medicine. Whilst once thought of being a dietary toxin, the focus on plant lectins has since shifted to understanding the useful properties of these lectins and utilizing them in medicinal applications to advance human health. This chapter reviews the current and potential applications of plant lectins in various areas of medically related research.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Human Immunodeficiency Virus</kwd><kwd>Plant Lectin</kwd><kwd>Ribosome Inactivate Protein</kwd><kwd>Black Soybean</kwd><kwd>Mistletoe Lectin</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media Dordrecht 2013</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>The word &#x0201c;lectin&#x0201d; originates from the Latin word &#x0201c;<italic>lego</italic>&#x0201d; which means, &#x0201c;to choose&#x0201d; or &#x0201c;pick out&#x0201d; [<xref ref-type="bibr" rid="CR1">1</xref>]. Lectins are defined as sugar-binding proteins that are neither antibodies nor enzymes [<xref ref-type="bibr" rid="CR2">2</xref>]. According to Rudiger and Gabius (2001), a glycoprotein must meet three distinct requirements to qualify as a lectin. Firstly, a lectin is a protein/glycoprotein that binds carbohydrate(s). Secondly, lectins are not immunoglobulins (antibodies). Thirdly, lectins do not biochemically modify the carbohydrates which they bind [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p>Lectins were first discovered more than 100&#x000a0;years ago in plants, when in 1888, Stillmark found that extracts of castor bean (<italic>Ricinus communis</italic>) seeds contained a protein that could agglutinate animal red blood cells [<xref ref-type="bibr" rid="CR4">4</xref>]. Following the discovery of Stillmark, a number of other plant seed extracts demonstrated the same ability to agglutinate red blood cells, but escalating interest in lectins was sparked during the Second World War as a result of the awareness of using lectins for blood typing. Because some lectins were found to be specific for various blood types (A, B or O), and others were found to have specificities for different glycans, lectins were used for blood typing before blood transfusions were performed [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Lectins have since been found in almost every plant species studied and are particularly abundant in the seeds of leguminous plants. They have also been found in various tissues and organs of many vertebrates and invertebrates [<xref ref-type="bibr" rid="CR7">7</xref>]. Due to their biochemical properties, lectins have become a beneficial tool in several fields of biological research including immunology [<xref ref-type="bibr" rid="CR8">8</xref>], study of membrane structure, cell recognition [<xref ref-type="bibr" rid="CR9">9</xref>], cancer research [<xref ref-type="bibr" rid="CR10">10</xref>], and clinical microbiology [<xref ref-type="bibr" rid="CR11">11</xref>]. 10.1007/978-94-007-6214-5_2 in this book provides more interesting stories regarding the history of lectinology.</p><p>Despite a lack of complete understanding of their biological roles, lectins have been exploited for several years in many applications. The use of lectins has facilitated advancements in many areas of medical research. Lectins are promising candidates as useful therapeutic agents because they can recognize specific carbohydrate structures such as proteoglycans, glycoproteins, and glycolipids, resulting in the regulation of various cells via glycoconjugates and their physiological and pathological phenomena through host-pathogen interactions and cell&#x02013;cell communications [<xref ref-type="bibr" rid="CR12">12</xref>].</p></sec><sec id="Sec2"><title>Types of Plant Lectins</title><p>Plant lectins can be categorized based on their overall mature structure into merolectins, hololectins, chimerolectins and superlectins (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">5.1</xref>a). Firstly, merolectins are small monomeric lectins consisting exclusively of a single carbohydrate-binding domain. Due to their monovalent nature, they do not possess agglutinating activity, such as hevein isolated from the latex of <italic>Hevea brasiliensis</italic> [<xref ref-type="bibr" rid="CR13">13</xref>]. Figure&#x000a0;<xref rid="Fig1" ref-type="fig">5.1</xref>b shows the crystal structure of hevein with (4s)-2-methyl-2,4-pentanediol. Next are hololectins, also exclusively built up of carbohydrate-binding domains but containing at least two such domains that are either identical or very homologous and bind either the same or structurally similar sugar(s), and most plant lectins are included in this subgroup. One example is Concanavalin A which is a tetrameric protein and binds specifically &#x003b1;-<sc>d</sc>-mannosyl and &#x003b1;-<sc>d</sc>-glucosyl residues (two hexoses differing only by the alcohol on carbon 2). A refined structure of Concanavalin A with mannose at 2.0 angstroms resolution is shown in Fig. <xref rid="Fig1" ref-type="fig">5.1</xref>b [<xref ref-type="bibr" rid="CR14">14</xref>]. Another example is peanut (<italic>Arachis hypogaea</italic>) agglutinin [<xref ref-type="bibr" rid="CR15">15</xref>]. It is a 110-kDa, homotetrameric non-glycosylated protein (without RIP activity) and shows a specificity for the tumor-associated T-antigenic disaccharide Gal<italic>&#x003b2;</italic>1,3GalNAc. The third group is chimerolectins, which are fusion proteins consisting of one or more carbohydrate-binding domain(s) tandemly arrayed to an unrelated domain. An example of this is ricin, which can be classified as both lectin and type II ribosome inactivating protein (RIP) [<xref ref-type="bibr" rid="CR16">16</xref>]. As shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">5.1</xref>b, ricin consists of two parts; an A chain (with N-glycosidase activity/RIP activity) and a B chain (hemagglutinating/lectin activity) with the B chain capable of binding different carbohydrates, such as &#x003b2;-<sc>d</sc>-glucose and &#x003b2;-<sc>d</sc>-galactose as shown in the figure. Lastly, superlectins are a type of chimerolectins which consist of at least two structurally different domains which recognize structurally unrelated carbohydrates [<xref ref-type="bibr" rid="CR17">17</xref>]. For instance, TxLC-I is a superlectin isolated from tulip bulbs, and it consists of a mannose-binding domain and an unrelated GalNAc-binding domain. Since there is no crystal data on plant superlectin, the crystal structure of a superlectin purified from <italic>Burkholderia cepacia</italic> (a Gram-negative bacterium), named BC2L-A, is used for demonstration (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">5.1</xref>b) [<xref ref-type="bibr" rid="CR18">18</xref>]. The N-terminal domain of BC2L-A is a novel TNF-&#x003b1;-like fucose-binding lectin while the C-terminal is a calcium-dependent bacterial lectin.<fig id="Fig1"><label>Fig.&#x000a0;5.1</label><caption><p>Classifications of plant lectins and the crystal structures of representative plant lectins under the classification standard of mature structure. Crystal data were from RCSB protein data bank and visualized by the UCSF chimera software as used previously [<xref ref-type="bibr" rid="CR23">23</xref>]. Protein crystal structures were from PROTEIN DATA BANK: Hevein (PDB ID: 1Q9B); Concanavalin A (PDB ID: 5CNA) [<xref ref-type="bibr" rid="CR14">14</xref>]; Ricin (PDB ID: 2AAI) [<xref ref-type="bibr" rid="CR16">16</xref>]; Peanut agglutinin (PDB ID: 1CR7); BC2L-C (N-terminal domain: 2WQ4; C-terminal domain: 2XR4) [<xref ref-type="bibr" rid="CR18">18</xref>]. Please note that BC2L-C is a bacterial lectin since currently no crystal structure of plant superlectin has been released. The coil, helix and strand are shown in <italic>dark grey, red and green</italic>, respectively</p></caption><graphic xlink:href="311316_1_En_5_Fig1_HTML" id="MO1"/></fig>
</p><p>Plant lectins can also be grouped into different families according to some common features (legume lectins, type II ribosome-inactivating proteins, monocot mannose-binding lectins, and other lectins) [<xref ref-type="bibr" rid="CR19">19</xref>]. Legume lectins are the best known lectin family. Lectin content in seeds is higher compared to the content in the bark, leaves, roots and stems of leguminous plants. Other smaller families of plants whose lectins have been characterized are Gramineae (cereals, such as wheat germ) and Solanaceae (potatoes and tomatoes). Monocot-binding lectins exhibit an exclusive specificity towards mannose and are built up of 1, 2, 3, or 4 subunits of about 12&#x000a0;kDa while chitin-binding lectins are composed of hevein domains [<xref ref-type="bibr" rid="CR20">20</xref>]. For more information, readers are referred to an excellent review by Van Damme et al. (1998) describing in detail how plant lectins are structurally and evolutionarily related [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p>Because of the tremendous diversity of carbohydrate-binding specificities among the plant lectins, some researchers classify them according to the small carbohydrate haptens they recognize, e.g., galactose-binding lectins or GlcNAc-binding lectins (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">5.1</xref>a). The specificity of a lectin is usually defined in terms of the monosaccharide(s) or glycosaccharides that inhibit lectin-induced agglutination [<xref ref-type="bibr" rid="CR22">22</xref>]. This specificity is usually determined by comparing sugars on the basis of the minimum concentration needed to inhibit hemagglutination. If the lectin-binding carbohydrate is present freely dissolved and at a sufficiently high concentration, it will compete with the red cell glycoconjugates for the lectin and agglutination will not take place.</p></sec><sec id="Sec3"><title>Medicinal Applications of Plant Lectins</title><p>Due to their versatility, lectins are frequently used in biological and medical research. The overwhelming success of plant lectins is based firstly on their highly specific carbohydrate-binding activity, and the biological effects they provoke in various organisms. Being able to procure reasonable amounts of pure lectin preparations also contributes to their success [<xref ref-type="bibr" rid="CR20">20</xref>]. Consequently, screening of plant species in the search for lectins with new and useful biological properties has been taking place for several decades.</p><sec id="Sec4"><title>Plant Lectins in Serology</title><p>Because of their ability to distinguish carbohydrate determinants in human blood cells, lectins have historically been used for blood typing. Serology was the first discipline of medicine that relies on the specific biological activity of lectins [<xref ref-type="bibr" rid="CR24">24</xref>]. Lectins agglutinate erythrocytes by binding to a carbohydrate-containing moiety on the surface of the cells and forming cross-bridges between them [<xref ref-type="bibr" rid="CR4">4</xref>]. This useful property of lectins endows them the ability to discriminate between red blood cells that have different terminal, non-reducing sugars in the major glycoprotein that carries the blood group antigens [<xref ref-type="bibr" rid="CR25">25</xref>]. For example, blood group A is determined by the presence of N-acetyl-galactosamine in the terminal, non-reducing end of the oligosaccharide portion of the receptor protein while group B is determined by galactose in this position. If both of these sugars are lacking, fucose is the terminal sugar and this determines blood group O. In this way, lectins with different specificities can be used in blood typing to differentiate between blood types. For readers seeking a comprehensive compilation of lectins that have been studied for blood group serology, the review by Judd (1980) is recommended [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec5"><title>Plant Lectins as Mitogens</title><p>A limited number of lectins from plants possess the unique ability to induce quiescent lymphocytes to grow and divide, a phenomenon known as mitogenic stimulation [<xref ref-type="bibr" rid="CR27">27</xref>]. Mitogenic lectins mimic the action of antigens on lymphocytes, except that they activate a large proportion (as much as 70&#x02013;80&#x000a0;%) of the cells, whereas antigens stimulate only specific clones, each of which compromise a tiny proportion, 0.1&#x000a0;% or less, of the total number of lymphocytes. Because of their ability to stimulate multiple lymphocyte clones, lectins are classified as polyclonal mitogens. One of the most valuable outcomes of this proliferative ability of lectins has been an increased understanding of the relationship between chromosomal abnormality and human diseases, which has tremendously helped in diagnosis [<xref ref-type="bibr" rid="CR28">28</xref>]. Besides other cells, lymphocytes have been the usual target cells for mitogenic assays, and the study of lectin-lymphocyte interaction has made a significant contribution to elucidating the mechanism of lymphocyte activation and its control, further contributing to the understanding of cell growth and development.</p><p>The discovery of the first mitogenic lectin was made by Nowell in 1960, who found that the lectin of red kidney bean (<italic>Phaseolus vulgaris</italic>), known as phytohemagglutinin (PHA), possessed the ability to stimulate lymphocytes to undergo mitosis [<xref ref-type="bibr" rid="CR29">29</xref>]. This discovery had a groundbreaking impact on immunology as it shattered the then prevailing opinion that lymphocytes were dead-end cells incapable of dividing or differentiating further [<xref ref-type="bibr" rid="CR29">29</xref>]. Within a short time thereafter, several other lectins were proven to be mitogenic. Table&#x000a0;<xref rid="Tab1" ref-type="table">5.1</xref> provides a few examples of plant lectins with mitogenic activity as such a lectin from the tuber of wild cobra lily [<xref ref-type="bibr" rid="CR30">30</xref>], red kidney bean lectin [<xref ref-type="bibr" rid="CR31">31</xref>], mushroom lectins [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], Brazilian camaratu bean lectin [<xref ref-type="bibr" rid="CR34">34</xref>], and jackfruit seed lectin [<xref ref-type="bibr" rid="CR35">35</xref>] .<table-wrap id="Tab1"><label>Table&#x000a0;5.1</label><caption><p>Mitogenic activity of selected plant lectins</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Lectin</th><th align="left">MW (kDa)</th><th align="left">Carbohydrate specificity</th><th align="left">Cells</th><th align="left">Activity</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">AFL</td><td align="left">13.5</td><td align="left">Asialofetuin</td><td align="left">BALB/c splenocytes</td><td align="left">increase in IL-2</td><td align="left">[<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td align="left">DRKBL</td><td align="left">67</td><td align="left">&#x02013;</td><td align="left">BALB/c splenocytes</td><td align="left">Lower than Con A</td><td align="left">[<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td align="left">GCL</td><td align="left">18</td><td align="left">Galactose</td><td align="left">BALB/c splenocytes</td><td align="left">More potent than Con A</td><td align="left">[<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td align="left">VVL</td><td align="left">12.6</td><td align="left">Thyroglobulin</td><td align="left">Mouse T cells</td><td align="left">10 fold more effective than Con A</td><td align="left">[<xref ref-type="bibr" rid="CR33">33</xref>]</td></tr><tr><td align="left">CML</td><td align="left">&#x02013;</td><td align="left">Mannose/Glucose</td><td align="left">Human lymphocytes</td><td align="left">Similar activity to Con A at 0.78 &#x02013; 25&#x000a0;&#x003bc;g/ml dosage</td><td align="left">[<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td align="left">Jacalin</td><td align="left">50</td><td align="left"><p>Galactose</p><p>Mannose</p></td><td align="left">Human lymphocytes</td><td align="left">33.7&#x000a0;&#x000b1;&#x000a0;15&#x000a0;&#x000d7;&#x000a0;10<sup>3</sup> ct/min</td><td align="left">[<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>AFL</italic> a lectin from tubers of <italic>Arisaema flavum</italic> (Schott.); <italic>DRKBL</italic> a lectin from <italic>Phaseolus vulgaris</italic> cv. Dark Red Kidney Bean; <italic>GCL</italic><italic>Ganoderma capense</italic> lectin; <italic>Con A</italic> Concanavalin A; <italic>VVL</italic><italic>Volvariella volvacea</italic> lectin; <italic>CML</italic><italic>Cratylia mollis</italic> seed lectin; <italic>Jacalin</italic> Jackfruit (<italic>Artocarpus heterophyllus</italic>) seed lectin
</p></table-wrap-foot></table-wrap>
</p><p>Concanavalin A, a lectin from the Jack bean, is an important mitogen because, in contrast to PHA, its activity can be inhibited by low concentrations of monosaccharides, for example, mannose. This finding provided proof that mitogenic stimulation is the result of binding of lectins to sugars on the surface of the lymphocytes and was among the earliest demonstrations for a biological role of cell surface sugars [<xref ref-type="bibr" rid="CR36">36</xref>]. It has been suggested that mitogenic lectins interact with unique membrane components that may act as &#x02018;stimulating receptors&#x02019;, and that non-mitogenic lectins may not bind to these membrane components [<xref ref-type="bibr" rid="CR28">28</xref>]. Mitogenic lectins are now tools for the study of signal transmission into cells and for the analysis of the biochemical events that occur during lymphocyte stimulation in vitro [<xref ref-type="bibr" rid="CR36">36</xref>]. Such properties make them useful tools for the isolation and characterization of polysaccharides and glycoconjugates, in cancer research, as diagnostic tools for the investigation of early cell-membrane alterations and carbohydrate changes that accompany neoplastic processes, and in immunological studies.</p></sec><sec id="Sec6"><title>Plant Lectins in Cancer Therapy</title><p>Cancer is one of the leading causes of death worldwide. Cancer is a deadly disease, where the abnormal behavior of a single cell type is difficult to treat by chemotherapy. It is important in cancer therapy that the treatment targets only the affected cells, leaving the normal cells undisturbed, which is quite difficult, especially in chemotherapy. Anti-cancer drugs available in the current market are not target-specific and elicit several side-effects and complications encountered in the clinical management of various forms of cancer, which highlights the urgent need for novel effective and less-toxic therapeutic approaches [<xref ref-type="bibr" rid="CR37">37</xref>]. Recently, focus has shifted from using lectins to detect cancer to actually using lectins to combat cancer.</p><p>Evidence is now emerging that lectins are dynamic contributors to tumor cell recognition (surface markers), cell adhesion and localization, signal transduction across membranes, mitogenic stimulation, augmentation of host immune defense, cytotoxicity, and apoptosis [<xref ref-type="bibr" rid="CR38">38</xref>]. A review by De Mejia and Prisecaru (2005) provides a comprehensive appraisal of the inhibitory effects of plant lectins on malignant cells in vitro and vivo [<xref ref-type="bibr" rid="CR39">39</xref>]. Table&#x000a0;<xref rid="Tab2" ref-type="table">5.2</xref> below adds some more recent selected plant lectins and lists their inhibitory effects on malignant cells.<table-wrap id="Tab2"><label>Table&#x000a0;5.2</label><caption><p>Inhibitory effects of selected plant lectins on malignant cells</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Lectin</th><th align="left">MW (kDa)</th><th align="left">Carbohydrate specificity</th><th align="left">Antiproliferative activity (IC<sub>50</sub>)</th><th align="left">Mechanism of action</th><th align="left">References</th></tr></thead><tbody><tr><td align="left" rowspan="2">BTKL</td><td align="left" rowspan="2">60</td><td align="left" rowspan="2">Polygalacturonic acid</td><td align="left" rowspan="2">HepG2 (7.9&#x000a0;&#x003bc;M)</td><td align="left">Apoptosis induction</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td align="left">Mitochondria damage</td></tr><tr><td align="left">FVML</td><td align="left">12</td><td align="left">&#x02013;</td><td align="left">L1210 (13&#x000a0;&#x003bc;M)</td><td align="left">&#x02013;</td><td align="left">[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td align="left" rowspan="3">GCML</td><td align="left" rowspan="3">18</td><td align="left" rowspan="3">Galactose/galactosamine</td><td align="left">L1210 (8&#x000a0;&#x003bc;M)</td><td align="left" rowspan="3">&#x02013;</td><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td align="left">Hep G2 (16.5&#x000a0;&#x003bc;M)</td></tr><tr><td align="left">M1 (12.5&#x000a0;&#x003bc;M)</td></tr><tr><td align="left" rowspan="2">PAL</td><td align="left" rowspan="2">32</td><td align="left" rowspan="2">Inulin</td><td align="left">Hep G2 (2.1&#x000a0;&#x003bc;M)</td><td align="left" rowspan="2">&#x02013;</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td align="left">MCF7 (3.2&#x000a0;&#x003bc;M)</td></tr><tr><td align="left">CNL</td><td align="left">15.9</td><td align="left">Asialofetuin and lactose</td><td align="left">leukemic T (100&#x000a0;&#x003bc;g/ml)</td><td align="left">binding to carbohydrate receptors on leukemic T cells</td><td align="left">[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td align="left" rowspan="2">HCSL</td><td align="left" rowspan="2">29</td><td align="left" rowspan="2"><sc>D</sc>-galactose and <italic>N</italic>-acetyl-<sc>D</sc>galactosamine</td><td align="left">HeLa (9&#x000a0;&#x003bc;g/ml)</td><td align="left" rowspan="2">Displayed a cytotoxic effect</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td align="left">FemX (11&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left" rowspan="5">ML-1</td><td align="left" rowspan="5">63</td><td align="left" rowspan="5">Galactose</td><td align="left">UISO-Mel6 (73.6&#x000a0;ng/ml)</td><td align="left" rowspan="5">Induction of apoptosis</td><td align="left" rowspan="5">[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td align="left">MeWo (5084.0&#x000a0;ng/ml)</td></tr><tr><td align="left">FemX-1 (1.9&#x000a0;ng/ml)</td></tr><tr><td align="left">Lox (10.5&#x000a0;ng/ml)</td></tr><tr><td align="left">G361 (0.6&#x000a0;ng/ml)</td></tr><tr><td align="left">Con A</td><td align="left">104</td><td align="left">Mannose/Glucose</td><td align="left">A375 (25&#x000a0;&#x003bc;g/ml)</td><td align="left">Inducing apoptosis in both casp-8 and casp-9-dependent ways</td><td align="left">[<xref ref-type="bibr" rid="CR46">46</xref>] [<xref ref-type="bibr" rid="CR47">47</xref>]</td></tr><tr><td align="left">DRKBL</td><td align="left">67</td><td align="left">&#x02013;</td><td align="left">L1210 (1.6&#x000a0;&#x003bc;M)</td><td align="left">&#x02013;</td><td align="left">[<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td align="left" rowspan="2">GML</td><td align="left" rowspan="2">50</td><td align="left" rowspan="2">Melibiose</td><td align="left">MCF7 (2.6&#x000a0;&#x003bc;M)</td><td align="left" rowspan="2">&#x02013;</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td align="left">HepG2 (4.1&#x000a0;&#x003bc;M)</td></tr><tr><td align="left" rowspan="3">DBL</td><td align="left" rowspan="3">30</td><td align="left" rowspan="3">Fructose</td><td align="left">L1210 (3.6&#x000a0;&#x003bc;M)</td><td align="left" rowspan="2">Cytokine-inducing</td><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td align="left" rowspan="2">HepG2 (25&#x000a0;&#x003bc;M)</td></tr><tr><td align="left">No production</td></tr><tr><td align="left">EAPL</td><td align="left">60</td><td align="left">Galactose</td><td align="left">Hep G2 (34.8&#x000a0;&#x003bc;M)</td><td align="left">Apoptosis-inducing</td><td align="left">[<xref ref-type="bibr" rid="CR50">50</xref>]</td></tr><tr><td align="left" rowspan="2">AFL</td><td align="left" rowspan="2">13.5</td><td align="left" rowspan="2">Asialofetuin</td><td align="left">J774</td><td align="left" rowspan="2"/><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td align="left">P388D1</td></tr><tr><td align="left" rowspan="3">MCL</td><td align="left" rowspan="3">130</td><td align="left" rowspan="3"><sc>d</sc>-galactose and &#x003b1;-lactose</td><td align="left">CNE 1 (6.9&#x000a0;&#x003bc;M)</td><td align="left" rowspan="2">Inducing apoptosis in both casp-8 and casp-9-dependent pathways;</td><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td align="left" rowspan="2">CNE 2 (7.4&#x000a0;&#x003bc;M)</td></tr><tr><td align="left">Damage of mitochondria</td></tr><tr><td align="left" rowspan="3">TDL</td><td align="left" rowspan="3">48</td><td align="left" rowspan="3">Mannose</td><td align="left">Pro-01 (56.7&#x000a0;&#x003bc;M)</td><td align="left" rowspan="3"/><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td align="left">Bre-04 (41.5&#x000a0;&#x003bc;M)</td></tr><tr><td align="left">Lu-04 (11.4&#x000a0;&#x003bc;M)</td></tr><tr><td align="left">SAL</td><td align="left">40</td><td align="left">Galactose</td><td align="left">HeLa (6.25&#x000a0;&#x003bc;M)</td><td align="left">&#x02013;</td><td align="left">[<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic> BTKL</italic><italic>Phaseolus vulgaris</italic><italic>cv.</italic> Blue tiger king lectin; <italic>FVML</italic><italic>Flammulina velutipes</italic> mushroom lectin; <italic>GCML</italic><italic>Ganoderma capense</italic> mushroom lectin; <italic>PAL</italic><italic>Pholiota adipose</italic> mushroom lectin; <italic>CNL</italic> Ricin B-like lectin from mushroom <italic>Clitocybe nebularis</italic>; <italic>HCSL</italic><italic>Haliclona crater</italic> sponge lectin; <italic>ML-1</italic> European mistletoe lectin; <italic>Con A</italic> Concanavalin A; <italic>DRKBL</italic> Dark red kidney bean (<italic>Phaseolus vulgaris</italic> cv.) lectin; <italic>GML</italic> small glossy black soybean (<italic>Glycine max</italic>) lectin; DBL, <italic>Del Monte</italic> banana lectin; <italic>EAPL</italic><italic>Phaseolus vulgaris</italic> cv. Extralong autumn purple bean lectin; <italic>AFL</italic> lectin from tubers of Wild Cobra Lily <italic>Arisaema flavum</italic>; <italic>MCL</italic><italic>Momordica Charantia</italic> lectin; <italic>TDL</italic> lectin from fresh tubers of a medicinal herb <italic>Typhonium Divaricatum</italic>; <italic>SAL</italic> lectin from seeds of <italic>Sophora alopecuroide</italic></p></table-wrap-foot></table-wrap>
</p><p>Small glossy black soybean (<italic>Glycine max</italic>) lectin inhibited the proliferation of breast cancer and hepatoma cells [<xref ref-type="bibr" rid="CR48">48</xref>]. An anti-tumor action mechanism of soybean lectins has been proposed involving the action of the lectins on tumor cell membranes, the reduction of tumor cell proliferation, the induction of tumor-specific cytotoxicity of macrophages, and apoptosis. Thus, tumor cells are more susceptible to attack by macrophages after treatment with lectins. Furthermore, lectins exert an immunomodulatory effect by altering interleukins production [<xref ref-type="bibr" rid="CR54">54</xref>].</p><p>Mistletoe lectin (ML) is one of the most studied lectins in clinical trials and has demonstrated beneficial effects against cancer development. Additionally their mechanisms of action towards cancer treatment have been extensively studied. For example, in a study using European mistletoe lectin which demonstrated antiproliferative activity towards human melanoma cells, a significant number of melanoma cells started rounding up and exhibited cell shrinkage, chromatin condensation and nuclear fragmentation typical for apoptotic body formation indicating apoptotic cell death [<xref ref-type="bibr" rid="CR45">45</xref>]. Three mistletoe lectins, I, II and III (ML-I, II, III) have been isolated [<xref ref-type="bibr" rid="CR55">55</xref>]. Mistletoe lectin-I, which belongs to the type II ribosome-inactivating protein (RIP II) family and is composed of a catalytically active A-chain with rRNA N-glycosidase activity and a B-chain with carbohydrate binding properties, exerted potent cytotoxic effects on tumor cells. It also induced apoptosis through both caspase-8/FLICE independent of a death receptor pathway and via a p53-independent pathway following ionizing radiation. Meanwhile, mistletoe lectin-II induced apoptotic death in cancer cells involving the generation of intracellular hydrogen peroxide (H2O2) and activation of a caspase- 9-caspase-3 cascade [<xref ref-type="bibr" rid="CR46">46</xref>].</p><p>The oral consumption of mistletoe lectins as an alternative therapy towards cancer therapy has been advocated by some parties as these lectins are resistant towards low pH in the stomach and are not affected by proteolytic enzymes in the stomach [<xref ref-type="bibr" rid="CR56">56</xref>]. Pryme et al. (2007) provide a meticulous case report with more information on this topic [<xref ref-type="bibr" rid="CR56">56</xref>]. However, the usefulness of mistletoe extracts in the treatment of malignant melanoma is still controversial for some. This may be in part due to the fact that the full molecular mechanisms underlying mistletoe treatment and how it works <italic>in vivo</italic> are still not completely clarified.</p><p>Lectins from several types of mushroom have demonstrated anti-proliferative activity including those from <italic>Flammulina velutipes</italic> [<xref ref-type="bibr" rid="CR41">41</xref>], <italic>Ganoderma capense</italic> [<xref ref-type="bibr" rid="CR32">32</xref>], <italic>Pholiota adipose</italic> [<xref ref-type="bibr" rid="CR42">42</xref>] and <italic>Clitocybe nebularis</italic> [<xref ref-type="bibr" rid="CR43">43</xref>]. A homodimeric 32.4-kDa lectin was isolated from fresh fruiting bodies of the mushroom <italic>Pleurotus citrinopileatus</italic> [<xref ref-type="bibr" rid="CR57">57</xref>]. The lectin exerted strong anti-tumor activity in mice bearing sarcoma 180, and caused approximately 80&#x000a0;% inhibition of tumor growth when administered intraperitoneally at 5&#x000a0;mg/kg daily for a period of 20&#x000a0;days.</p><p>As many plant lectins have demonstrated anticancer properties in vitro, and <italic>in vivo</italic>, there clearly is a huge potential for their use as therapeutic agents in cancer treatment. Mechanisms of plant lectin action elucidated thus far include preferential binding to cancer cell membranes or their receptors, causing cytotoxicity, apoptosis, and inhibition of tumor growth. Plant lectins can be internalized into cells, causing cancer cell agglutination and/or aggregation [<xref ref-type="bibr" rid="CR54">54</xref>]. Ingested lectins can also sequester the available body pool of polyamines, in this manner they prevent cancer cell growth. The immune system is also affected by alterations in the production of various interleukins, or by activation of certain protein kinases. Additionally, lectins can bind to ribosomes and inhibit protein synthesis. They also alter the cell cycle by inducing non-apoptotic G1-phase accumulation mechanisms, G2/M phase cell cycle arrest and apoptosis, and can trigger the caspase cascade. Lectins can also down-regulate telomerase activity and inhibit angiogenesis [<xref ref-type="bibr" rid="CR54">54</xref>].</p><p>Future advances in cancer prevention, detection, and treatment could potentially be achieved by using plant lectins. These substances possess antitumor activity and anti-carcinogenic activity that could be beneficial in cancer treatment.</p></sec><sec id="Sec7"><title>Plant Lectins as Antiviral Agents</title><p>Compounds with antiviral activity are generally of great medical interest and different modes of pharmaceutical actions have been described. The antiviral activity of plant lectins can be based on several mechanisms. The surfaces of retroviruses such as human immunodeficiency virus (HIV) and many other enveloped viruses are covered by virally-encoded glycoproteins. Glycoproteins gp120 and gp41 present on the HIV envelope are heavily glycosylated, with glycans estimated to contribute almost 50&#x000a0;% of the molecular weight of gp120. Agents that specifically and strongly interact with the glycans may disturb interactions between the proteins of the viral envelope and the cells of the host [<xref ref-type="bibr" rid="CR58">58</xref>]. Sugar-binding proteins can crosslink glycans on the viral surface and prevent further interactions with the co-receptors.</p><p>HIV RT is a key enzyme of the HIV life cycle. Screening of HIV RT inhibitors is currently a strategy to search for anti-HIV drugs. Strikingly, the vast majority of plant lectins that are active against HIV possess carbohydrate specificity directed against mannose oligomers. Most HIV-inhibitory plant lectins are derived from the monocot families <italic>Amaryllidaceae</italic>, <italic>Orchidaceae</italic> and <italic>Alliaceae</italic> or the dicot families <italic>Fabaceae</italic>, <italic>Moraceae</italic>, <italic>Urticaceae</italic> and <italic>Cecropiaceae</italic> [<xref ref-type="bibr" rid="CR58">58</xref>]. Table&#x000a0;<xref rid="Tab3" ref-type="table">5.3</xref> lists several plant lectins such as <italic>Phaseolus vulgaris</italic> cv. Extralong autumn purple bean lectin [<xref ref-type="bibr" rid="CR50">50</xref>], Del Monte banana lectin [<xref ref-type="bibr" rid="CR49">49</xref>], black soybean lectin [<xref ref-type="bibr" rid="CR48">48</xref>] and <italic>Pholiota adipose</italic> mushroom lectin [<xref ref-type="bibr" rid="CR42">42</xref>] which all possessed anti-HIV RT activity.<table-wrap id="Tab3"><label>Table&#x000a0;5.3</label><caption><p>Antiviral activity of selected plant lectins</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Name</th><th align="left">MW (kDa)</th><th align="left">Carbohydrate specificity</th><th align="left">Anti-Viral activity (shown in MIC or as indicated)</th><th align="left">Mechanism of action</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">EAPL</td><td align="left">60</td><td align="left">Galactose</td><td align="left">HIV-1 (1.8&#x000a0;&#x003bc;M)</td><td align="left">&#x02013;</td><td align="left">[<xref ref-type="bibr" rid="CR50">50</xref>]</td></tr><tr><td align="left">DBL</td><td align="left">30</td><td align="left">Fructose</td><td align="left">HIV-1 (3&#x000a0;mM)</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td align="left">APA</td><td align="left">&#x02013;</td><td align="left">Mannose</td><td align="left">Sars CoV corona virus (0.45&#x000a0;&#x003bc;g/ml)</td><td align="left">Disruption of virus replication cycle</td><td align="left">[<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr><tr><td align="left">SGBSL</td><td align="left">50</td><td align="left">Melibiose</td><td align="left">HIV-1 (2.82&#x000a0;&#x003bc;M)</td><td align="left"/><td align="left">[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td align="left">PAL</td><td align="left">32</td><td align="left">Inulin</td><td align="left">HIV-1 (1.9&#x000a0;&#x003bc;M)</td><td align="left">&#x02013;</td><td align="left">[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td align="left" rowspan="2">TDL</td><td align="left" rowspan="2">48</td><td align="left" rowspan="2">Mannose</td><td align="left" rowspan="2">HSV-II (3.1&#x000a0;&#x003bc;g/ml)</td><td align="left">Bind on high-mannose</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td align="left">glycans on the surface of the virus particles</td></tr><tr><td align="left">CVN</td><td align="left">11</td><td align="left">&#x02013;</td><td align="left">HIV-1 laboratory strain RF (0.1 nM)</td><td align="left">Binding on HIV surface envelope glycoprotein gp120</td><td align="left">[<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]</td></tr><tr><td align="left" rowspan="2">CVN</td><td align="left" rowspan="2">11</td><td align="left" rowspan="2">&#x02013;</td><td align="left">EboZV GP (50 nM)</td><td align="left" rowspan="2">&#x02013;</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR62">62</xref>]</td></tr><tr><td align="left">Marburg GP (6-25 nM)</td></tr><tr><td align="left" rowspan="11">CVN</td><td align="left" rowspan="11">11</td><td align="left" rowspan="11">&#x02013;</td><td align="left">Influenza A Virus Strains:</td><td align="left">CV-N bound directly to and inactivated the</td><td align="left" rowspan="11">[<xref ref-type="bibr" rid="CR63">63</xref>]</td></tr><tr><td align="left">Sydney/05/07 (H3N3, 0.04&#x000a0;&#x003bc;g/ml)</td><td align="left" rowspan="10">viral particle</td></tr><tr><td align="left">Victoria/3/75 (H3N3, 0.005&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left">Mem/8/99 (H3N3, 0.03&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left">Mem/2/99 (H3N3, 0.15&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left">Beijing/262/95 (H1N1, 0.11&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left">Influenza B Virus Strains:</td></tr><tr><td align="left">Hong Kong/5/72 (0.5&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left">Yamanashi/166/98 (0.04&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left">Mem/3/99 (0.02&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left">Lee/40 (0.026&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left">CLL</td><td align="left">12</td><td align="left">Mannose</td><td align="left">Poxvirus (around 30&#x000a0;&#x003bc;g/ml)</td><td align="left">&#x02013;</td><td align="left">[<xref ref-type="bibr" rid="CR64">64</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>EAPL</italic><italic>Phaseolus vulgaris</italic> cv. Extralong autumn purple bean lectin; <italic>DBL</italic><italic>Del Monte</italic> banana lectin; <italic>APA</italic> plant lectin isolated from leek; <italic>SGBSL</italic> small glossy black soybean (<italic>Glycine max</italic>) lectin; <italic>PAL</italic><italic>Pholiota adiposa</italic> mushroom lectin; <italic>TDL</italic> lectin from fresh tubers of a medicinal herb <italic>Typhonium divaricatum</italic> (L.) Decne; <italic>CVN</italic> blue green algae <italic>Nostoc ellipsosporum</italic> lectin; <italic>CLL</italic> lectin from <italic>Crinum latifolium</italic> bulb; <italic>HIV-1</italic> human immunodeficiency virus type 1; HSV-II herpes simplex virus type 2</p></table-wrap-foot></table-wrap>
</p><p>Studies on plant lectins such as those from leek (Table&#x000a0;<xref rid="Tab3" ref-type="table">5.3</xref>) have shown that they can be potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle [<xref ref-type="bibr" rid="CR59">59</xref>]. The first target was located early in the replication cycle, most probably viral attachment, and the second target was located at the end of the infectious virus cycle. The antiviral activity spectrum of plant lectins varies considerably, depending on the nature of their sugar specificity. In general, the mannose-specific plant lectins were found to be highly effective against coronaviruses [<xref ref-type="bibr" rid="CR59">59</xref>].</p><p>A lectin from blue green algae (CV-N) exhibited a broad range of antiviral activities. It has been shown that CV-N binds with high affinity to HIV envelope protein gp120 [<xref ref-type="bibr" rid="CR61">61</xref>] and also interacts with another surface glycoprotein, gp41 [<xref ref-type="bibr" rid="CR63">63</xref>]. The specificity of CV-N, however, is not limited only to different strains of HIV and related retroviruses. CV-N inhibited the development of viral cytopathic effects of Ebola virus, binding to its surface envelope glycoprotein [<xref ref-type="bibr" rid="CR62">62</xref>] and also blocked influenza A and B strains by binding to the hemagglutinin surface glycoprotein [<xref ref-type="bibr" rid="CR63">63</xref>]. The results of viral pretreatment studies indicated that CV-N directly neutralized both influenza A and B viruses, including both H1N1 and H3N2 strains. However, the CV-N resistant influenza virus strain A/PR/8/34 was completely resistant to any direct neutralizing activity. Results suggested that CV-N bound directly to and inactivated the viral particle, preventing subsequent infection, and that both the likely molecular target for CV-N and the basis of CV-N resistance resided in the viral particle [<xref ref-type="bibr" rid="CR63">63</xref>].</p><p>Unlike the majority of current antiviral therapeutics that act through inhibition of the viral life cycle, lectins can prevent penetration of the host cells by the viruses [<xref ref-type="bibr" rid="CR60">60</xref>]. Antiviral lectins are best suited to topical applications and can exhibit lower toxicity than many currently used antiviral therapeutics. Additionally, these proteins are often resistant to high temperatures and low pH, as well as being odorless, which are favorable properties for potential microbicide drugs [<xref ref-type="bibr" rid="CR60">60</xref>]. The mechanistic details on how lectins operate at a molecular level to inhibit virus growth need to be further explored to know the basis of their biological activity.</p></sec><sec id="Sec8"><title>Plant Lectins as Antibacterial and Antifungal Agents</title><p>The growing resistance of microorganisms to convectional antimicrobial agents is a source of concern to clinical microbiologists all over the world. As a result, efforts are being made to develop antimicrobial agents from local sources for better chemotherapeutic effects. Lectins from plants could satisfy the demand for more natural antimicrobials as several studies have demonstrated the effectiveness of lectins as inhibitory compounds towards bacterial and fungal growth such as the examples listed in Table&#x000a0;<xref rid="Tab4" ref-type="table">5.4</xref>. Plant lectins have demonstrated antibacterial activity against many pathogens including <italic>Escherichia coli</italic>, <italic>Shigella dysenteriae</italic>, <italic>Staphylococcus aureus</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Bacillus subtilis</italic>, and <italic>Klebsiella sp</italic>. Lectins have also demonstrated antifungal activity towards <italic>Aspergillus flavus,</italic>
<italic>Trichoderma viride, Fusarium oxysporum, Fusarium moniliforme, Coprinus comatus, Rhizoctonia olani, Penicillium digitatum, Alternaria</italic>
<italic>alternata</italic>, and <italic>Valsa mali.</italic> The use of lectins in clinical microbiology in a review by Slifkin and Doyle (1990) [<xref ref-type="bibr" rid="CR11">11</xref>] as well as the antimicrobial activity from plant lectins article by Paiva et al. (2010) [<xref ref-type="bibr" rid="CR65">65</xref>] is recommended for readers who seek further detailed information.<table-wrap id="Tab4"><label>Table&#x000a0;5.4</label><caption><p>Antimicrobial activity of selected plant lectins</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Name</th><th align="left">Antimicrobial activity</th><th align="left">Lectin Specificity</th><th align="left">Anti-microorganism activity (MIC or as indicated)</th><th align="left">References</th></tr></thead><tbody><tr><td align="left" rowspan="3">MOL</td><td align="left" rowspan="3">Antibacterial</td><td align="left" rowspan="3">&#x02013;</td><td align="left">
<italic>E. coli</italic>
</td><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td align="left">
<italic>Shigella dysenteriae</italic>
</td></tr><tr><td align="left">
<italic>Staphylococcus aureus</italic>
</td></tr><tr><td align="left" rowspan="6">EUL</td><td align="left" rowspan="6">Antibacterial</td><td align="left" rowspan="6">&#x02013;</td><td align="left"><italic>S. aureus</italic> (1.5&#x000a0;&#x003bc;g/ml)</td><td align="left" rowspan="6">[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td align="left"><italic>P. aeruginosa</italic> (1.5&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left"><italic>Klebsiella</italic> sp. (1.5&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left"><italic>Bacillus subtilis</italic> (16.5&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left"><italic>Streptococcus</italic> sp. (16.5&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left"><italic>Escherichia coli</italic> (16.5&#x000a0;&#x003bc;g/ml)</td></tr><tr><td align="left" rowspan="3">AJL</td><td align="left">Antibacterial</td><td align="left" rowspan="3"/><td align="left"><italic>Bacillus subtilis</italic> (0.227&#x000a0;mg/ml)</td><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR68">68</xref>]</td></tr><tr><td align="left" rowspan="2">Antifungal</td><td align="left"><italic>S. aureus</italic> (0.0567&#x000a0;mg/ml)</td></tr><tr><td align="left"><italic>C. albicans</italic> (0.0567&#x000a0;mg/ml)</td></tr><tr><td align="left" rowspan="3">PSL</td><td align="left" rowspan="3">Antifungal</td><td align="left" rowspan="3">Mannose</td><td align="left"><italic>Aspergillus flavus</italic> (0.1&#x000a0;mg/ml)</td><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR69">69</xref>]</td></tr><tr><td align="left"><italic>Trichoderma viride</italic>(0.01&#x000a0;mg/ml)</td></tr><tr><td align="left"><italic>Fusarium oxysporum.</italic> (0.01&#x000a0;mg/ml)</td></tr><tr><td align="left" rowspan="2">CFL</td><td align="left" rowspan="2">Antifungal</td><td align="left" rowspan="2">Mannose/glucose</td><td align="left"><italic>Fusarium. moniliforme</italic> (-)</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR70">70</xref>]</td></tr><tr><td align="left"><italic>Aspergillus. flavus.</italic> (-)</td></tr><tr><td align="left" rowspan="3">RKBL</td><td align="left" rowspan="3">Antifungal</td><td align="left" rowspan="3"/><td align="left"><italic>Fusarium oxysporum</italic> (-)</td><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR71">71</xref>]</td></tr><tr><td align="left"><italic>Coprinus comatus</italic> (-)</td></tr><tr><td align="left"><italic>Rhizoctonia solani</italic> (-)</td></tr><tr><td align="left" rowspan="2">SAL</td><td align="left" rowspan="2">Antifungal</td><td align="left" rowspan="2">Galactose</td><td align="left"><italic>Penicillium digitatum (</italic>IC<sub>50</sub>&#x000a0;=&#x000a0;3.125&#x000a0;&#x003bc;M)</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr><tr><td align="left"><italic>Alternaria alternate (</italic>IC<sub>50</sub>&#x000a0;=&#x000a0;3.338&#x000a0;&#x003bc;M)</td></tr><tr><td align="left">CSL</td><td align="left">Antifungal</td><td align="left">Galactose, lactose, arabinose, etc.</td><td align="left"><italic>Valsa mali (</italic>IC<sub>50</sub>&#x000a0;=&#x000a0;18&#x000a0;&#x003bc;M<italic>)</italic></td><td align="left">[<xref ref-type="bibr" rid="CR72">72</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic> MOL</italic> lectin purified from Drumstick (<italic>Moringa oleifera</italic> Lam.) leaves; <italic>EUL</italic><italic>Eugenia uniflora</italic> seed lectin; <italic>AJL</italic> lectin from seeds of <italic>Archidendron jiringa</italic>; <italic>PSL</italic> lectin from Egyptian <italic>Pisum sativum</italic> seeds; <italic>CFL</italic> lectin from red cluster pepper (<italic>Capsicum frutescens</italic>); <italic>RKBL</italic> lectins from red kidney bean; <italic>SAL</italic> Lectin from seeds of <italic>Sophora alopecuroides</italic>; <italic>CSL</italic> lectin from caper (<italic>Capparis spinosa</italic>) seeds</p></table-wrap-foot></table-wrap>
</p><p>The cell wall of bacteria not only precludes any interaction between the glycoconjugates on their membrane and carbohydrate-binding proteins but also prevents these proteins from penetrating the cytoplasm. Therefore, plant lectins cannot alter the structure and/or permeability of the membrane or disturb the normal intracellular processes of invading microbes. Therefore, if lectins play a role in the plant&#x02019;s defense against bacteria, it must be through an indirect mechanism that is based on interactions with cell wall carbohydrates or extracellular glycans [<xref ref-type="bibr" rid="CR73">73</xref>].</p><p>Similarly, plant lectins are not capable of binding to glycoconjugates on the fungal membranes or penetrating the cytoplasm due to the barrier formed by the cell wall. Thus, it is not likely that lectins directly inhibit fungal growth by changing the structure and/or permeability of the fungal membrane. However, there may be indirect effects produced by the binding of lectins to carbohydrates on the surface of the fungal cell wall [<xref ref-type="bibr" rid="CR74">74</xref>].</p><p>This activity was concluded to be related to the lectin carbohydrate binding property, that might endow lectin molecules with binding activity towards certain carbohydrate components in the fungal cell wall affecting its activity and viability as most lectins recognize either <italic>N</italic>-acetylneuraminic acid, <italic>N</italic>-acetylglucosamine, <italic>N</italic>-acetylgalactosamine, galactose, mannose, or fucose [<xref ref-type="bibr" rid="CR75">75</xref>]. Alternatively, it was stated that antifungal activity of some proteins or peptides is associated with chitin binding property and the active proteins should have a specific amino acid sequence and a cysteine/glycine rich chitin binding domain. This chitin binding property might simulate the carbohydrate binding property as chitin is composed of modified glucose subunits (<italic>N</italic>-acetyl glucose amine) which can be equally recognized by lectin as glucose [<xref ref-type="bibr" rid="CR69">69</xref>]. Chitin binding might lead to the disruption of the fungal cell wall that increases toxicity, since chitin, which is a major component of the fungal wall, is a polymer of <italic>N</italic>-acetylglucosamine.</p></sec><sec id="Sec9"><title>Plant Lectins in Drug Targeting</title><p>The idea to use lectins for drug delivery began when the use of tomato lectin (TL) to target the luminal surface of the small intestine was proposed [<xref ref-type="bibr" rid="CR76">76</xref>]. The underlying principle behind lectin-mediated drug targeting is that most cell surface proteins and many lipids in cell membranes are glycosylated and these glycans can be the binding sites for lectins. The combination of a small number of sugars can produce a vast range of different chemical structures. Different cell types express different glycan arrays and diseased cells, such as transformed or cancerous cells, often express different glycans compared with their normal counterparts. Therefore, lectins could be used as carrier molecules to target drugs specifically to different cells and tissues [<xref ref-type="bibr" rid="CR77">77</xref>]. By targeting cell types exclusively, the side effects of drugs could be minimized. Besides targeting specific cells, the lectin&#x02013;sugar interaction can also been used to trigger vesicular transport into or across epithelial cells. The concept of bio-adhesion via lectins may be applied not only for the gastrointestinal tract [<xref ref-type="bibr" rid="CR76">76</xref>] but also for other biological barriers like the nasal mucosa, the lungs, the buccal cavity, the eye [<xref ref-type="bibr" rid="CR78">78</xref>] and the blood&#x02013;brain barrier [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. Table&#x000a0;<xref rid="Tab5" ref-type="table">5.5</xref> lists some examples of plant lectins from tomato [<xref ref-type="bibr" rid="CR76">76</xref>], potato [<xref ref-type="bibr" rid="CR78">78</xref>], wheat germ [<xref ref-type="bibr" rid="CR79">79</xref>] and peanut [<xref ref-type="bibr" rid="CR80">80</xref>] which have been studied to investigate their potential of use as drug targeting agents.<table-wrap id="Tab5"><label>Table&#x000a0;5.5</label><caption><p>Potential drug targeting use of selected plant lectins</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Name</th><th align="left">Source</th><th align="left">Carbohydrate specificity</th><th align="left">MW (kDa)</th><th align="left">Potential use</th><th align="left">References</th></tr></thead><tbody><tr><td align="left" rowspan="3">AEL</td><td align="left" rowspan="3">Tomato</td><td align="left" rowspan="3">(GlcNAc)<sub>4</sub>
</td><td align="left" rowspan="3">71</td><td align="left">Intestinal wall</td><td align="left" rowspan="2">[<xref ref-type="bibr" rid="CR76">76</xref>]</td></tr><tr><td align="left" rowspan="2">Bioadhesive in the GI tract</td></tr><tr><td align="left">[<xref ref-type="bibr" rid="CR81">81</xref>]</td></tr><tr><td align="left">STL</td><td align="left">Potato</td><td align="left">N-acetyl-<sc>d</sc>-glucosamine</td><td align="left">&#x02013;</td><td align="left">Ocular (Corneal and conjunctival)</td><td align="left">[<xref ref-type="bibr" rid="CR78">78</xref>]</td></tr><tr><td align="left" rowspan="4">WGA</td><td align="left" rowspan="4">Wheat germ</td><td align="left" rowspan="2">N-acetyl-<sc>d</sc>-glucosamine</td><td align="left" rowspan="4">38</td><td align="left">Blood brain barrier</td><td align="left" rowspan="3">[<xref ref-type="bibr" rid="CR79">79</xref>]</td></tr><tr><td align="left" rowspan="3">Intestinal mucosal surface</td></tr><tr><td align="left" rowspan="2">Sialic acid</td></tr><tr><td align="left">[<xref ref-type="bibr" rid="CR82">82</xref>]</td></tr><tr><td align="left">PNA</td><td align="left">Peanut</td><td align="left"><sc>d</sc>-galactose</td><td align="left">110</td><td align="left">Intestinal mucosal surface</td><td align="left">[<xref ref-type="bibr" rid="CR80">80</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>AEL</italic><italic>Lycopersicon esculenttun</italic> lectin; <italic>STL</italic><italic>Solanum tuberosum</italic> lectin. <italic>WGA</italic> Wheat germ agglutinin; <italic>PNA</italic><italic>Arachis hypogaea</italic> lectin
</p></table-wrap-foot></table-wrap>
</p><p>Attempts to evaluate the binding of lectin candidates to non-histologically processed cell surfaces, must be done in order to systematically identify the appropriate receptors and lectin types for further studies. Further work will more precisely locate the lectin binding site on the tissue surface and will quantify the binding. Lectin toxicity and <italic>in vivo</italic> binding will then be considered prior to selecting the most promising candidates for formulation studies [<xref ref-type="bibr" rid="CR78">78</xref>]. Lectins such as WGA could be useful as specific bioadhesive ligands for lipid nanoparticles intended for oral administration [<xref ref-type="bibr" rid="CR82">82</xref>] once the bioadhesive properties and oral bioavailability efficiency are determined.</p><p>Results from preliminary studies performed so far can be taken as an indication that it may indeed be possible to exploit lectins of certain carbohydrate specificities for oral drug delivery and intestinal targeting. However, a great deal of research remains to be done before lectins can be used in practice. For a more thorough understanding, readers are directed to reviews by Lehr (2000) and Bies et al. (2004) which provides more information on lectin-mediated drug delivery and targeting, from their history to applications [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR83">83</xref>].</p></sec></sec><sec id="Sec10"><title>Outlooks and Perspectives</title><p>Plant lectins have been and still are a subject of intense investigation. They have come a long way, since their first detection in plants as hemagglutinins, to their present status as recognition molecules with innumerable exciting functions and applications. As more plant lectins are isolated and further studies are conducted on the biological activities and mechanisms of action of lectins, the production of lectins can be improved and new applications of these lectins will be found or conceived. Lectins could be used as the next generation of medicines once research has contributed to their full understanding.</p><p>More research is still needed and a genomic and proteomic approach to elucidate and support the potential shown by lectins as anticancer, antimicrobial and drug delivery agents is warranted. The mechanistic details of how lectins operate at a molecular level need to be further explored to know the basis of their biological activity. Although there is still much to be learned about the effects of lectins, the area of research concerning plant lectins is constantly evolving and being updated. Thus the medicinal applications of plant lectins hold considerable potential and exciting discoveries lie ahead.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>WC</given-names></name><name><surname>Shapleigh</surname><given-names>E</given-names></name></person-group><article-title>Antigenic relations of blood group antigens as suggested by tests with lectins</article-title><source>J Immunol</source><year>1954</year><volume>73</volume><fpage>226</fpage><lpage>231</lpage><?supplied-pmid 13201765?><pub-id pub-id-type="pmid">13201765</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barondes</surname><given-names>SH</given-names></name></person-group><article-title>Bifunctional properties of lectins: lectins redefined</article-title><source>Trends Biochem Sci</source><year>1988</year><volume>13</volume><fpage>480</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/0968-0004(88)90235-6</pub-id><?supplied-pmid 2855286?><pub-id pub-id-type="pmid">2855286</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000fc;diger</surname><given-names>H</given-names></name><name><surname>Gabius</surname><given-names>HJ</given-names></name></person-group><article-title>Plant lectins: occurrence, biochemistry, functions and applications</article-title><source>Glycoconj J</source><year>2001</year><volume>18</volume><fpage>589</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1023/A:1020687518999</pub-id><?supplied-pmid 12376725?><pub-id pub-id-type="pmid">12376725</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liener</surname><given-names>IE</given-names></name></person-group><article-title>Seed hemagglutinins</article-title><source>Econ Bot</source><year>1964</year><volume>18</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1007/BF02903999</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renkonen</surname><given-names>KO</given-names></name></person-group><article-title>Studies on hemagglutinins present in seeds of some representatives of the family of Leguminoseae</article-title><source>Annales Medicinae Experimentalis et Biologiae Fenniae</source><year>1948</year><volume>26</volume><fpage>66</fpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>WC</given-names></name><name><surname>Reguera</surname><given-names>RM</given-names></name></person-group><article-title>Hemagglutinating substances for human cells in various plants</article-title><source>J Immunol</source><year>1949</year><volume>62</volume><fpage>333</fpage><lpage>339</lpage><?supplied-pmid 18132346?><pub-id pub-id-type="pmid">18132346</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>IJ</given-names></name><name><surname>Hughes</surname><given-names>RC</given-names></name><name><surname>Monsigny</surname><given-names>M</given-names></name><name><surname>Osawa</surname><given-names>T</given-names></name><name><surname>Sharon</surname><given-names>N</given-names></name></person-group><article-title>What should be called a lectin</article-title><source>Nature</source><year>1980</year><volume>285</volume><fpage>66</fpage><pub-id pub-id-type="doi">10.1038/285066b0</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>T</given-names></name></person-group><article-title>Evolution of the lectin-complement pathway and its role in innate immunity</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><fpage>346</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1038/nri800</pub-id><?supplied-pmid 12033740?><pub-id pub-id-type="pmid">12033740</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>N</given-names></name><name><surname>Lis</surname><given-names>H</given-names></name></person-group><article-title>Lectins as cell recognition molecules</article-title><source>Science</source><year>1989</year><volume>246</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1126/science.2552581</pub-id><?supplied-pmid 2552581?><pub-id pub-id-type="pmid">2552581</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mody</surname><given-names>R</given-names></name><name><surname>Joshi</surname><given-names>SH</given-names></name><name><surname>Chaney</surname><given-names>W</given-names></name></person-group><article-title>Use of lectins as diagnostic and therapeutic tools for cancer</article-title><source>J Pharmacol Toxicol Methods</source><year>1995</year><volume>33</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/1056-8719(94)00052-6</pub-id><?supplied-pmid 7727802?><pub-id pub-id-type="pmid">7727802</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slifkin</surname><given-names>M</given-names></name><name><surname>Doyle</surname><given-names>RJ</given-names></name></person-group><article-title>Lectins and their application to clinical microbiology</article-title><source>Clin Microbiol Rev</source><year>1990</year><volume>3</volume><fpage>197</fpage><lpage>218</lpage><?supplied-pmid 2200603?><pub-id pub-id-type="pmid">2200603</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Ogawa T., Watanabe M., Naganuma T., Muramoto K. (2011) Diversified carbohydrate-binding lectins from marine resources. J Amino Acids 2011 </mixed-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes-Lopez</surname><given-names>CA</given-names></name><name><surname>Hernandez-Santoyo</surname><given-names>A</given-names></name><name><surname>Pedraza-Escalona</surname><given-names>M</given-names></name><name><surname>Mendoza</surname><given-names>G</given-names></name><name><surname>Hernandez-Arana</surname><given-names>A</given-names></name><name><surname>Rodriguez-Romero</surname><given-names>A</given-names></name></person-group><article-title>Insights into a conformational epitope of Hev b 6.02 (hevein)</article-title><source>Biochem Biophys Res Commun</source><year>2004</year><volume>314</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2003.12.068</pub-id><?supplied-pmid 14715255?><pub-id pub-id-type="pmid">14715255</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naismith</surname><given-names>J.H.</given-names></name><name><surname>Emmerich</surname><given-names>C.</given-names></name><name><surname>Habash</surname><given-names>J.</given-names></name><name><surname>Harrop</surname><given-names>S.J.</given-names></name><name><surname>Helliwell</surname><given-names>J.R.</given-names></name><name><surname>Hunter</surname><given-names>W.N.</given-names></name><etal/></person-group><article-title>Refined structure of concanavalin A complexed with methyl alpha-D-mannopyranoside at 2.0 A resolution and comparison with the saccharide-free structure</article-title><source>Acta crystallographica. Section D, Biol crystallogr</source><year>1994</year><volume>50</volume><fpage>847</fpage><lpage>858</lpage></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravishankar</surname><given-names>R</given-names></name><name><surname>Thomas</surname><given-names>CJ</given-names></name><name><surname>Suguna</surname><given-names>K</given-names></name><name><surname>Surolia</surname><given-names>A</given-names></name><name><surname>Vijayan</surname><given-names>M</given-names></name></person-group><article-title>Crystal structures of the peanut lectin-lactose complex at acidic pH: retention of unusual quaternary structure, empty and carbohydrate bound combining sites, molecular mimicry and crystal packing directed by interactions at the combining site</article-title><source>Proteins</source><year>2001</year><volume>43</volume><fpage>260</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1002/prot.1037</pub-id><?supplied-pmid 11288176?><pub-id pub-id-type="pmid">11288176</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutenber</surname><given-names>E</given-names></name><name><surname>Katzin</surname><given-names>BJ</given-names></name><name><surname>Ernst</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>EJ</given-names></name><name><surname>Mlsna</surname><given-names>D</given-names></name><name><surname>Ready</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Crystallographic refinement of ricin to 2.5 A</article-title><source>Proteins</source><year>1991</year><volume>10</volume><fpage>240</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1002/prot.340100308</pub-id><?supplied-pmid 1881880?><pub-id pub-id-type="pmid">1881880</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Van Damme E.J.M., Peumans W.J., Pusztai A., Bardocz S. (1998) Handbook of plant lectins: prop biomed appl, Wiley</mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulak</surname><given-names>O</given-names></name><name><surname>Cioci</surname><given-names>G</given-names></name><name><surname>Lameignere</surname><given-names>E</given-names></name><name><surname>Balloy</surname><given-names>V</given-names></name><name><surname>Round</surname><given-names>A</given-names></name><name><surname>Gutsche</surname><given-names>I</given-names></name><etal/></person-group><article-title>Burkholderia cenocepacia BC2L-C is a super lectin with dual specificity and proinflammatory activity</article-title><source>PLoS Pathog</source><year>2011</year><volume>7</volume><fpage>e1002238</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002238</pub-id><?supplied-pmid 21909279?><pub-id pub-id-type="pmid">21909279</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>SK</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>Lectins: production and practical applications</article-title><source>Appl Microbiol Biotechnol</source><year>2011</year><volume>89</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2892-9</pub-id><?supplied-pmid 20890754?><pub-id pub-id-type="pmid">20890754</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peumans</surname><given-names>W</given-names></name><name><surname>Van Damme</surname><given-names>EJ</given-names></name></person-group><article-title>Plant lectins: versatile proteins with important perspectives in biotechnology</article-title><source>Biotechnol Genet Eng Rev</source><year>1988</year><volume>15</volume><fpage>199</fpage><lpage>228</lpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Damme</surname><given-names>EJM</given-names></name><name><surname>Peumans</surname><given-names>WJ</given-names></name><name><surname>Barre</surname><given-names>A</given-names></name><name><surname>Roug&#x000e9;</surname><given-names>P</given-names></name></person-group><article-title>Plant lectins: A composite of several distinct families of structurally and evolutionary related proteins with diverse biological roles</article-title><source>Crit Rev Plant Sci</source><year>1998</year><volume>17</volume><fpage>575</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1080/07352689891304276</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Goldstein I.J., Hughes R.C., Monsigny M., Osawa T., Sharon N. (1980) What should be called a lectin?, Published online: 08 May 1980; | doi:10.1038/285066b0 285: 66</mixed-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>EF</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>Ribonucleases of different origins with a wide spectrum of medicinal applications</article-title><source>Biochim Biophys Acta</source><year>1815</year><volume>2011</volume><fpage>65</fpage><lpage>74</lpage></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko&#x00144;ska</surname><given-names>G</given-names></name><name><surname>W&#x000f3;jtowicz</surname><given-names>U</given-names></name><name><surname>Pituch-Noworolska</surname><given-names>A</given-names></name></person-group><article-title>Possible application of lectins in diagnostics and therapy</article-title><source>Part I. Diagnostic application. Przeglad lekarski</source><year>2008</year><volume>65</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">18724546</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sequeira</surname><given-names>L</given-names></name></person-group><article-title>Lectins and their role in host-pathogen specificity</article-title><source>Annu Rev Phytopathol</source><year>1978</year><volume>16</volume><fpage>453</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1146/annurev.py.16.090178.002321</pub-id><?supplied-pmid 18643749?><pub-id pub-id-type="pmid">18643749</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judd</surname><given-names>WJ</given-names></name><name><surname>Issitt</surname><given-names>PD</given-names></name></person-group><article-title>The role of lectins in blood group serology</article-title><source>Crit Rev Clin Lab Sci</source><year>1980</year><volume>12</volume><fpage>171</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.3109/10408368009108729</pub-id><?supplied-pmid 6998652?><pub-id pub-id-type="pmid">6998652</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpatrick</surname><given-names>DC</given-names></name></person-group><article-title>Mechanisms and assessment of lectin-mediated mitogenesis</article-title><source>Mol Biotechnol</source><year>1999</year><volume>11</volume><fpage>55</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1007/BF02789176</pub-id><?supplied-pmid 10367282?><pub-id pub-id-type="pmid">10367282</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>M.T.</given-names></name><name><surname>Khan</surname><given-names>R.H.</given-names></name></person-group><article-title>Mitogenic lectins</article-title><source>Med Sci Monit</source><year>2003</year><volume>9</volume><fpage>RA265</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">14586291</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>N</given-names></name></person-group><article-title>Lectins: Carbohydrate-specific reagents and biological recognition molecules</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>2753</fpage><lpage>2764</lpage><pub-id pub-id-type="doi">10.1074/JBC.X600004200</pub-id><?supplied-pmid 17145746?><pub-id pub-id-type="pmid">17145746</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Kamboj</surname><given-names>SS</given-names></name></person-group><article-title>A novel mitogenic and antiproliferative lectin from a wild cobra lily</article-title><source>Arisaema flavum. Biochem. Biophys. Res. Commun.</source><year>2004</year><volume>318</volume><fpage>1057</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.04.135</pub-id><pub-id pub-id-type="pmid">15147981</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>L</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>A hemagglutinin with mitogenic activity from dark red kidney beans</article-title><source>J Chromatogr B</source><year>2006</year><volume>844</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2006.07.042</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngai</surname><given-names>PHK</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>A mushroom (Ganoderma capense) lectin with spectacular thermostability, potent mitogenic activity on splenocytes, and antiproliferative activity toward tumor cells</article-title><source>Biochem Biophys Res Commun</source><year>2004</year><volume>314</volume><fpage>988</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2003.12.196</pub-id><?supplied-pmid 14751230?><pub-id pub-id-type="pmid">14751230</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>J.C.K.</given-names></name><name><surname>Sze</surname><given-names>S.C.W.</given-names></name><name><surname>Shen</surname><given-names>W.Z.</given-names></name><name><surname>Liu</surname><given-names>W.K.</given-names></name></person-group><article-title>Mitogenic activity of edible mushroom lectins. Biochimica et Biophysica Acta (BBA)</article-title><source>General Subjects</source><year>2004</year><volume>1671</volume><fpage>9</fpage><lpage>17</lpage></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciel</surname><given-names>EVM</given-names></name><name><surname>Ara&#x000c3;&#x000ba;jo-Filho</surname><given-names>VS</given-names></name><name><surname>Nakazawa</surname><given-names>M</given-names></name><name><surname>Gomes</surname><given-names>YM</given-names></name><name><surname>Coelho</surname><given-names>LCBB</given-names></name><name><surname>Correia</surname><given-names>MTS</given-names></name></person-group><article-title>Mitogenic activity of Cratylia mollis lectin on human lymphocytes</article-title><source>Biologicals</source><year>2004</year><volume>32</volume><fpage>57</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.biologicals.2003.12.001</pub-id><?supplied-pmid 15026026?><pub-id pub-id-type="pmid">15026026</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pineau</surname><given-names>N</given-names></name><name><surname>Aucouturier</surname><given-names>P</given-names></name><name><surname>Brugier</surname><given-names>JC</given-names></name><name><surname>Preud&#x02019;homme</surname><given-names>JL</given-names></name></person-group><article-title>Jacalin: a lectin mitogenic for human CD4 T lymphocytes</article-title><source>Clin Exp Immunol</source><year>1990</year><volume>80</volume><fpage>420</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.1990.tb03304.x</pub-id><?supplied-pmid 2372991?><pub-id pub-id-type="pmid">2372991</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>N</given-names></name><name><surname>Lis</surname><given-names>H</given-names></name></person-group><article-title>History of lectins: from hemagglutinins to biological recognition molecules</article-title><source>Glycobiology</source><year>2004</year><volume>14</volume><fpage>53R</fpage><lpage>62R</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwh122</pub-id><?supplied-pmid 15229195?><pub-id pub-id-type="pmid">15229195</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Goyal</surname><given-names>A</given-names></name></person-group><article-title>Recent developments in mushrooms as anti-cancer therapeutics: a review. 3</article-title><source>Biotech</source><year>2012</year><volume>2</volume><fpage>1</fpage><lpage>15</lpage></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mody</surname><given-names>R</given-names></name><name><surname>Joshi</surname><given-names>S</given-names></name><name><surname>Chaney</surname><given-names>W</given-names></name></person-group><article-title>Use of lectins as diagnostic and therapeutic tools for cancer</article-title><source>J Pharmacol Toxicol Methods</source><year>1995</year><volume>33</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/1056-8719(94)00052-6</pub-id><?supplied-pmid 7727802?><pub-id pub-id-type="pmid">7727802</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Mej&#x000ed;a</surname><given-names>EG</given-names></name><name><surname>Prisecaru</surname><given-names>VI</given-names></name></person-group><article-title>Lectins as bioactive plant proteins: a potential in cancer treatment</article-title><source>Crit Rev Food Sci Nutr</source><year>2005</year><volume>45</volume><fpage>425</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1080/10408390591034445</pub-id><?supplied-pmid 16183566?><pub-id pub-id-type="pmid">16183566</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>EF</given-names></name><name><surname>Pan</surname><given-names>WL</given-names></name><name><surname>Wong</surname><given-names>JH</given-names></name><name><surname>Chan</surname><given-names>YS</given-names></name><name><surname>Ye</surname><given-names>XJ</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>A new Phaseolus vulgaris lectin induces selective toxicity on human liver carcinoma Hep G2 cells</article-title><source>Arch Toxicol</source><year>2011</year><volume>85</volume><fpage>1551</fpage><lpage>1563</lpage><pub-id pub-id-type="doi">10.1007/s00204-011-0698-x</pub-id><?supplied-pmid 21445585?><pub-id pub-id-type="pmid">21445585</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>TB</given-names></name><name><surname>Ngai</surname><given-names>PHK</given-names></name><name><surname>Xia</surname><given-names>L</given-names></name></person-group><article-title>An agglutinin with mitogenic and antiproliferative activities from the mushroom Flammulina velutipes</article-title><source>Mycologia</source><year>2006</year><volume>98</volume><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.3852/mycologia.98.2.167</pub-id><?supplied-pmid 16894961?><pub-id pub-id-type="pmid">16894961</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>GQ</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>HX</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa</article-title><source>Acta Biochim Pol</source><year>2009</year><volume>56</volume><fpage>415</fpage><lpage>421</lpage><?supplied-pmid 19636442?><pub-id pub-id-type="pmid">19636442</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohleven</surname><given-names>J</given-names></name><name><surname>Obermajer</surname><given-names>N</given-names></name><name><surname>Sabotic</surname><given-names>J</given-names></name><name><surname>Anzlovar</surname><given-names>S</given-names></name><name><surname>Sepci&#x00107;</surname><given-names>K</given-names></name><name><surname>Kos</surname><given-names>J</given-names></name><etal/></person-group><article-title>Purification, characterization and cloning of a ricin B-like lectin from mushroom Clitocybe nebularis with antiproliferative activity against human leukemic T cells</article-title><source>Biochim Biophys Acta</source><year>2009</year><volume>1790</volume><fpage>173</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2008.11.006</pub-id><?supplied-pmid 19100814?><pub-id pub-id-type="pmid">19100814</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pajic</surname><given-names>I</given-names></name><name><surname>Kljajic</surname><given-names>Z</given-names></name><name><surname>Dogovic</surname><given-names>N</given-names></name><name><surname>Sladic</surname><given-names>D</given-names></name><name><surname>Juranic</surname><given-names>Z</given-names></name><name><surname>Gasic</surname><given-names>MJ</given-names></name></person-group><article-title>A novel lectin from the sponge Haliclona cratera: isolation, characterization and biological activity</article-title><source>Comp Biochem Physiol C: Toxicol Pharmacol</source><year>2002</year><volume>132</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/S1532-0456(02)00068-6</pub-id><pub-id pub-id-type="pmid">12106898</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thies</surname><given-names>A</given-names></name><name><surname>Nugel</surname><given-names>D</given-names></name><name><surname>Pf&#x000fc;ller</surname><given-names>U</given-names></name><name><surname>Moll</surname><given-names>I</given-names></name><name><surname>Schumacher</surname><given-names>U</given-names></name></person-group><article-title>Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro</article-title><source>Toxicology</source><year>2005</year><volume>207</volume><fpage>105</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2004.09.009</pub-id><?supplied-pmid 15590126?><pub-id pub-id-type="pmid">15590126</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Min</surname><given-names>M-W</given-names></name><name><surname>Bao</surname><given-names>J-K</given-names></name></person-group><article-title>Induction of apoptosis by Concanavalin A and its molecular mechanisms in cancer cells</article-title><source>Autophagy</source><year>2009</year><volume>5</volume><fpage>432</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.4161/auto.5.3.7924</pub-id><?supplied-pmid 19202354?><pub-id pub-id-type="pmid">19202354</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name></person-group><article-title>Li C.-y., Bian H.-j., Min M.-w., Chen L.-f., Bao J.-k., Antiproliferative activity and apoptosis-inducing mechanism of Concanavalin A on human melanoma A375 cells</article-title><source>Arch Biochem Biophys</source><year>2009</year><volume>482</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2008.12.003</pub-id><?supplied-pmid 19111670?><pub-id pub-id-type="pmid">19111670</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Ng</surname><given-names>T</given-names></name></person-group><article-title>Purification of melibiose-binding lectins from two cultivars of Chinese black soybeans</article-title><source>Acta Biochim Biophys Sin</source><year>2008</year><volume>40</volume><fpage>1029</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1111/j.1745-7270.2008.00488.x</pub-id><?supplied-pmid 19089301?><pub-id pub-id-type="pmid">19089301</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>AHK</given-names></name><name><surname>Wong</surname><given-names>JH</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>Musa acuminata (Del Monte banana) lectin is a fructose-binding lectin with cytokine-inducing activity</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><fpage>594</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2008.12.016</pub-id><?supplied-pmid 19195858?><pub-id pub-id-type="pmid">19195858</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>EF</given-names></name><name><surname>Wong</surname><given-names>JH</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>Biochemical and functional properties of a lectin purified from korean large black soybeans&#x02013;a cultivar of glycine max</article-title><source>Protein Pept Lett</source><year>2010</year><volume>17</volume><fpage>690</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.2174/092986610791190309</pub-id><?supplied-pmid 19715533?><pub-id pub-id-type="pmid">19715533</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>EF</given-names></name><name><surname>Zhang</surname><given-names>CZY</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name><name><surname>Wong</surname><given-names>JH</given-names></name><name><surname>Pan</surname><given-names>WL</given-names></name><name><surname>Ye</surname><given-names>XJ</given-names></name><etal/></person-group><article-title>Momordica Charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and <italic>in vivo</italic></article-title><source>Cancer Prev Res (Phila)</source><year>2012</year><volume>5</volume><fpage>109</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-11-0203</pub-id><pub-id pub-id-type="pmid">21933914</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>A novel mannose-binding tuber lectin from Typhonium divaricatum (L.) Decne (family Araceae) with antiviral activity against HSV-II and anti-proliferative effect on human cancer cell lines</article-title><source>J Biochem Mol Biol</source><year>2007</year><volume>40</volume><fpage>358</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.5483/BMBRep.2007.40.3.358</pub-id><?supplied-pmid 17562287?><pub-id pub-id-type="pmid">17562287</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Lv</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name></person-group><article-title>Isolation and characterization of a novel lectin with antifungal and antiproliferative activities from Sophora alopecuroides seeds</article-title><source>Acta Biochim Biophys Sin</source><year>2012</year><volume>44</volume><fpage>606</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1093/abbs/gms037</pub-id><?supplied-pmid 22634632?><pub-id pub-id-type="pmid">22634632</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Mejia</surname><given-names>EG</given-names></name><name><surname>Bradford</surname><given-names>T</given-names></name><name><surname>Hasler</surname><given-names>C</given-names></name></person-group><article-title>The anticarcinogenic potential of soybean lectin and lunasin</article-title><source>Nutr Rev</source><year>2003</year><volume>61</volume><fpage>239</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1301/nr.2003.jul.239-246</pub-id><?supplied-pmid 12918876?><pub-id pub-id-type="pmid">12918876</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>U</given-names></name><name><surname>Stamouli</surname><given-names>A</given-names></name><name><surname>Adam</surname><given-names>E</given-names></name><name><surname>Peddie</surname><given-names>M</given-names></name><name><surname>Pfuller</surname><given-names>U</given-names></name></person-group><article-title>Biochemical, histochemical and cell biological investigations on the actions of mistletoe lectins I, II and III with human breast cancer cell lines</article-title><source>Glycoconj J</source><year>1995</year><volume>12</volume><fpage>250</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1007/BF00731327</pub-id><?supplied-pmid 7496139?><pub-id pub-id-type="pmid">7496139</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryme</surname><given-names>IF</given-names></name><name><surname>Tilrem</surname><given-names>P</given-names></name></person-group><article-title>Oral mistletoe lectins: A case for their use in cancer therapy</article-title><source>Cancer Ther</source><year>2007</year><volume>5</volume><fpage>287</fpage><lpage>300</lpage></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YR</given-names></name><name><surname>Liu</surname><given-names>QH</given-names></name><name><surname>Wang</surname><given-names>HX</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1780</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2007.09.004</pub-id><?supplied-pmid 17961926?><pub-id pub-id-type="pmid">17961926</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balzarini</surname><given-names>J</given-names></name></person-group><article-title>Inhibition of HIV entry by carbohydrate-binding proteins</article-title><source>Antiviral Res</source><year>2006</year><volume>71</volume><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2006.02.004</pub-id><?supplied-pmid 16569440?><pub-id pub-id-type="pmid">16569440</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keyaerts</surname><given-names>E</given-names></name><name><surname>Vijgen</surname><given-names>L</given-names></name><name><surname>Pannecouque</surname><given-names>C</given-names></name><name><surname>Van Damme</surname><given-names>E</given-names></name><name><surname>Peumans</surname><given-names>W</given-names></name><name><surname>Egberink</surname><given-names>H</given-names></name><etal/></person-group><article-title>Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle</article-title><source>Antiviral Res</source><year>2007</year><volume>75</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2007.03.003</pub-id><?supplied-pmid 17428553?><pub-id pub-id-type="pmid">17428553</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zi&#x000f3;&#x00142;kowska</surname><given-names>NE</given-names></name><name><surname>Wlodawer</surname><given-names>A</given-names></name></person-group><article-title>others, Structural studies of algal lectins with anti-HIV activity</article-title><source>Acta Biochim Pol</source><year>2006</year><volume>53</volume><fpage>617</fpage><lpage>626</lpage><?supplied-pmid 17128290?><pub-id pub-id-type="pmid">17128290</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>MR</given-names></name><name><surname>Gustafson</surname><given-names>KR</given-names></name><name><surname>McMahon</surname><given-names>JB</given-names></name><name><surname>Shoemaker</surname><given-names>RH</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>BR</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><etal/></person-group><article-title>Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development</article-title><source>Antimicrob Agents Chemother</source><year>1997</year><volume>41</volume><fpage>1521</fpage><lpage>1530</lpage><?supplied-pmid 9210678?><pub-id pub-id-type="pmid">9210678</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrientos</surname><given-names>LG</given-names></name><name><surname>Lasala</surname><given-names>F</given-names></name><name><surname>Otero</surname><given-names>JR</given-names></name><name><surname>Sanchez</surname><given-names>A</given-names></name><name><surname>Delgado</surname><given-names>R</given-names></name></person-group><article-title>In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins</article-title><source>J Infect Dis</source><year>2004</year><volume>189</volume><fpage>1440</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1086/382658</pub-id><?supplied-pmid 15073681?><pub-id pub-id-type="pmid">15073681</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Keefe</surname><given-names>BR</given-names></name><name><surname>Smee</surname><given-names>DF</given-names></name><name><surname>Turpin</surname><given-names>JA</given-names></name><name><surname>Saucedo</surname><given-names>CJ</given-names></name><name><surname>Gustafson</surname><given-names>KR</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><etal/></person-group><article-title>Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin</article-title><source>Antimicrob Agents Chemother</source><year>2003</year><volume>47</volume><fpage>2518</fpage><lpage>2525</lpage><pub-id pub-id-type="doi">10.1128/AAC.47.8.2518-2525.2003</pub-id><?supplied-pmid 12878514?><pub-id pub-id-type="pmid">12878514</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name></person-group><article-title>Singh Kamboj S., Singh J., J. Kotwal G., In vitro antiviral activity of <italic>Crinum latifolium</italic> lectin against poxvirus replication</article-title><source>Journal of Biological Sciences</source><year>2008</year><volume>8</volume><fpage>1236</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.3923/jbs.2008.1236.1240</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">Paiva P.M.G., Gomes F.S., Napole&#x000a0;&#x0223c;&#x000a0;ao T.H., S\&#x02019;a R.A., Correia M.T.S., Coelho L. (2010) Antimicrobial activity of secondary metabolites and lectins from plants. Curr Res Technol Educ Top Appl Microbiol Microb Biotechnol Badajoz: Formatex 396&#x02013;406</mixed-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatun</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>M.M.H.</given-names></name><name><surname>Ashraduzzaman</surname><given-names>M.</given-names></name><name><surname>Pervin</surname><given-names>F.</given-names></name><name><surname>Bari</surname><given-names>L.</given-names></name><name><surname>Absar</surname><given-names>N.</given-names></name></person-group><article-title>Antibacterial Activity and Cytotoxicity of Three Lectins Purified from Drumstick (Moringa oleifera Lam.) Leaves</article-title><source>J Bio-Sci</source><year>2009</year><volume>17</volume><fpage>89</fpage><lpage>94</lpage></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>M.d.l.</given-names></name><name><surname>Andrade</surname><given-names>C.a.s.</given-names></name><name><surname>Santos-Magalh&#x000e3;es</surname><given-names>N.s.</given-names></name><name><surname>Teixeira</surname><given-names>J.a.</given-names></name><name><surname>Carneiro-da-Cunha</surname><given-names>M.g.</given-names></name><etal/></person-group><article-title>Purification of a lectin from Eugenia uniflora L. seeds and its potential antibacterial activity</article-title><source>Lett Appl Microbiol</source><year>2008</year><volume>46</volume><fpage>371</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">18266644</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charungchitrak</surname><given-names>S</given-names></name><name><surname>Petsom</surname><given-names>A</given-names></name><name><surname>Sangvanich</surname><given-names>P</given-names></name><name><surname>Karnchanatat</surname><given-names>A</given-names></name></person-group><article-title>Antifungal and antibacterial activities of lectin from the seeds of Archidendron jiringa Nielsen</article-title><source>Food Chem</source><year>2011</year><volume>126</volume><fpage>1025</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2010.11.114</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sitohy</surname><given-names>M</given-names></name><name><surname>Doheim</surname><given-names>M</given-names></name><name><surname>Badr</surname><given-names>H</given-names></name></person-group><article-title>Isolation and characterization of a lectin with antifungal activity from Egyptian Pisum sativum seeds</article-title><source>Food Chem</source><year>2007</year><volume>104</volume><fpage>971</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2007.01.026</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngai</surname><given-names>PHK</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group><article-title>A lectin with antifungal and mitogenic activities from red cluster pepper (Capsicum frutescens) seeds</article-title><source>Appl Microbiol Biotechnol</source><year>2006</year><volume>74</volume><fpage>366</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1007/s00253-006-0685-y</pub-id><?supplied-pmid 17082928?><pub-id pub-id-type="pmid">17082928</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>XY</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name><name><surname>Tsang</surname><given-names>PW</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Isolation of a homodimeric lectin with antifungal and antiviral activities from red kidney bean (Phaseolus vulgaris) seeds</article-title><source>J Protein Chem</source><year>2001</year><volume>20</volume><fpage>367</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1023/A:1012276619686</pub-id><?supplied-pmid 11732688?><pub-id pub-id-type="pmid">11732688</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam Sze</surname><given-names>K.</given-names></name><name><surname>Han Qi</surname><given-names>F.</given-names></name><name><surname>Ng Tzi</surname><given-names>B.</given-names></name></person-group><article-title>Isolation and characterization of a lectin with potentially exploitable activities from caper (Capparis spinosa) seeds</article-title><source>Biosci Rep</source><year>2009</year><volume>29</volume><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">18847434</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="other">Peumans W.J., Van Damme E.J. (1995) Lectins as plant defense proteins. Plant physiology 109</mixed-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>JH</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name><name><surname>Cheung</surname><given-names>RCF</given-names></name><name><surname>Ye</surname><given-names>XJ</given-names></name><name><surname>Wang</surname><given-names>HX</given-names></name><name><surname>Lam</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Proteins with antifungal properties and other medicinal applications from plants and mushrooms</article-title><source>Appl Microbiol Biotechnol</source><year>2010</year><volume>87</volume><fpage>1221</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2690-4</pub-id><?supplied-pmid 20532758?><pub-id pub-id-type="pmid">20532758</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lis</surname><given-names>H</given-names></name><name><surname>Sharon</surname><given-names>N</given-names></name></person-group><article-title>Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition</article-title><source>Chem Rev</source><year>1998</year><volume>98</volume><fpage>637</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1021/cr940413g</pub-id><?supplied-pmid 11848911?><pub-id pub-id-type="pmid">11848911</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naisbett</surname><given-names>B</given-names></name><name><surname>Woodley</surname><given-names>J</given-names></name></person-group><article-title>The potential use of tomato lectin for oral drug delivery. 1. Lectin binding to rat small intestine in vitro</article-title><source>Int J Pharm</source><year>1994</year><volume>107</volume><fpage>223</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/0378-5173(94)90438-3</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bies</surname><given-names>C</given-names></name><name><surname>Lehr</surname><given-names>C-M</given-names></name><name><surname>Woodley</surname><given-names>JF</given-names></name></person-group><article-title>Lectin-mediated drug targeting: history and applications</article-title><source>Adv Drug Deliv Rev</source><year>2004</year><volume>56</volume><fpage>425</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2003.10.030</pub-id><?supplied-pmid 14969751?><pub-id pub-id-type="pmid">14969751</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholls</surname><given-names>TJ</given-names></name><name><surname>Green</surname><given-names>KL</given-names></name><name><surname>Rogers</surname><given-names>DJ</given-names></name><name><surname>Cook</surname><given-names>JD</given-names></name><name><surname>Wolowacz</surname><given-names>S</given-names></name><name><surname>Smart</surname><given-names>JD</given-names></name></person-group><article-title>Lectins in ocular drug delivery: An investigation of lectin binding sites on the corneal and conjunctival surfaces</article-title><source>Int J Pharm</source><year>1996</year><volume>138</volume><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/0378-5173(96)04540-1</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>D</given-names></name><name><surname>Kissel</surname><given-names>T</given-names></name></person-group><article-title>Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: implications for drug delivery</article-title><source>Eur J Pharm Biopharm</source><year>2001</year><volume>52</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0939-6411(01)00159-X</pub-id><?supplied-pmid 11438418?><pub-id pub-id-type="pmid">11438418</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Z-R</given-names></name></person-group><article-title>Lectin-mediated cytotoxicity and specificity of 5-fluorouracil conjugated with peanut agglutinin (5-Fu-PNA) in vitro</article-title><source>J Drug Target</source><year>2005</year><volume>13</volume><fpage>251</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1080/10611860500138505</pub-id><?supplied-pmid 16051537?><pub-id pub-id-type="pmid">16051537</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehr</surname><given-names>CM</given-names></name><name><surname>Bouwstra</surname><given-names>JA</given-names></name><name><surname>Kok</surname><given-names>W</given-names></name><name><surname>Noach</surname><given-names>AB</given-names></name><name><surname>de Boer</surname><given-names>AG</given-names></name><name><surname>Junginger</surname><given-names>HE</given-names></name></person-group><article-title>Bioadhesion by means of specific binding of tomato lectin</article-title><source>Pharm Res</source><year>1992</year><volume>9</volume><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1023/A:1015804816582</pub-id><?supplied-pmid 1495901?><pub-id pub-id-type="pmid">1495901</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin</article-title><source>Int J Pharm</source><year>2011</year><volume>419</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2011.07.019</pub-id><?supplied-pmid 21816211?><pub-id pub-id-type="pmid">21816211</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehr</surname><given-names>CM</given-names></name></person-group><article-title>Lectin-mediated drug delivery: the second generation of bioadhesives</article-title><source>Journal of controlled release: official journal of the Controlled Release Society</source><year>2000</year><volume>65</volume><fpage>19</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/S0168-3659(99)00228-X</pub-id><pub-id pub-id-type="pmid">10699266</pub-id></element-citation></ref></ref-list></back></article>